Objective: The study examined the prevalence and risk factors of hypertension in climacteric women living in rural areas of Türkiye. Material and Methods: It is a descriptive-relational study. This study found that hypertension prevalence was 40.8% with a confidence level of 95%, a test power of 95.98%, and an effect size of d=0.20, resulting in a sample size of 84. Post-hoc power analysis revealed a power of 99.99% with a sample size of 348. The researcher used a faceto-face questionnaire to gather data from 348 women who applied to the family health center and met the inclusion criteria. The data was analyzed using the IBM SPSS Statistics 23 software package, employing ttests, chi-square tests, and binary logistic regression analysis. Results: The study found that one out of three climacteric women had hypertension and that the majority of those who weren't aware had pre-hypertension or Stage 1 hypertension. In addition, hypertension was found to be significantly higher in climacteric women aged 56 to 64 who were married, did not consume fruit and vegetables regularly, and had been menopausal for 1 to 5 years (p<0.05), and it was more common in older, married, chronically ill, and obese women. Conclusion: Women in the climacteric period who have hypertension should receive information and awareness-raising services on the associated risk factors.
Keywords: Women; climacteric period; hypertension
Amaç: Araştırma, Türkiye'nin kırsal kesiminde yaşayan klimakterik dönemde olan kadınlarda hipertansiyon ve risk faktörlerini belirlemek amacıyla yapılmıştır. Gereç ve Yöntemler: Çalışma, betimsel-ilişkisel türdedir. Çalışmalara dayalı olarak hipertansiyon prevalansı %40,8 alınmış, %95 güven, %95,98 test gücü ve d=0,20 etki büyüklüğü ile örneklem büyüklüğü 84 olarak hesaplanmıştır. ''Post hoc'' güç analizi sonucuna göre aynı etki büyüklüğü ve 348 örneklem ile testin gücü %99,99 bulunmuştur. Araştırma, aile sağlığı merkezine başvuran dâhil edilme kriterlerine uyan 348 kadın ile yüz yüze görüşme yöntemiyle soru formu doldurularak gerçekleştirilmiştir. Veriler IBM SPSS Statistics 23 paket programı üzerinde t-testi, ki-kare testi ve ikili lojistik regresyon analizi kullanılarak yapılmıştır. Bulgular: Her üç klimakterik dönemde olan kadından birinde hipertansiyon olduğu, hipertansiyonun farkında olmayan kadınların çoğunluğunun prehipertansiyon ve Evre 1 hipertansiyon olduğu saptanmıştır. Ayrıca 56-64 yaş grubunda, evli, düzensiz meyve sebze tüketen, menopoza girme süresi 1-5 yıl olan klimakterik kadınlarda (p<0,05), yaşlılarda, evli, kronik hasta ve obez klimakterik kadınlarda hipertansiyon anlamlı derecede daha fazla saptanmıştır. Sonuç: Hipertansiyon sorunu yaşayan klimakterik dönemde olan kadınlara risk faktörleri konusunda eğitim ve farkındalık hizmeti verilmelidir.
Anahtar Kelimeler: Kadın; klimakterik dönem; hipertansiyon
- Blümel JE, Lavín P, Vallejo MS, Sarrá S. Menopause or climacteric, just a semantic discussion or has it clinical implications? Climacteric. 2014;17(3):235-41. [Crossref] [PubMed]
- Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553-e64. [Crossref] [PubMed] [PMC]
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19?1 million participants. Lancet. 2017;389(10064):37-55. Erratum in: Lancet. 2020;396(10255):886. [PubMed] [PMC]
- Arici M, Turgan C, Altun B, Sindel S, Erbay B, Derici U, et al; Turkish Society of Hypertension and Renal Diseases. Hypertension incidence in Turkey (HinT): a population-based study. J Hypertens. 2010;28(2):240-4. [Crossref] [PubMed]
- Chajaee F, Pirzadeh A, Hasanzadeh A, Mostafavi F. Relationship between health literacy and knowledge among patients with hypertension in Isfahan province, Iran. Electron Physician. 2018;10(3):6470-7. [PubMed] [PMC]
- Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199-206. [Crossref] [PubMed]
- Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169-80. [Crossref] [PubMed] [PMC]
- Dastan I, Erem A, Cetinkaya V. Awareness, treatment, control of hypertension, and associated factors: results from a Turkish national study. Clinical and Experimental Hypertension. 2018;40(1):90-8. [Crossref] [PubMed]
- Abramson B, Srivaratharajah K, Davis LL, Parapid B. Women and Hypertension: Beyond the 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. An Expert Analysis. 2018. [Link]
- Talukdar D, Tripathi M, Tripathi V, Teelucksingh S. Prevalence and associated factors of undiagnosed hypertension among women aged 15-49 years in India: an analysis of National Family Health Survey-4 data. J Hum Hypertens. 2021;35(8):726-40. Retraction in: J Hum Hypertens. 2022(10):944. [Crossref] [PubMed]
- Kılıçkap M, Barçın C, Göksülük H, Karaaslan D, Özer N, Kayıkçıoğlu M, et al. Türkiye'de hipertansiyon sıklığı ve kan basıncı verileri: kardiyovasküler risk faktörlerine yönelik epidemiyolojik çalışmaların sistematik derleme, meta-analiz ve meta-regresyonu [Data on prevalence of hypertension and blood pressure in Turkey: systematic review, meta-analysis and meta-regression of epidemiological studies on cardiovascular risk factors]. Turk Kardiyol Dern Ars. 2018;46(7):525-45. Turkish. [PubMed]
- Şahin N, Döner Güner P, Dirican E, Yengil E, Özer C. Birinci basamağa başvuran bireylerde hipertansiyon risk faktörleri [Hypertension risk factors of individuals in primary care]. Medical Journal of Mustafa Kemal University. 2018;9(35):128-35. [Crossref]
- Hacihasanoglu R, Inandi T, Yildirim A, Karakurt P, Saglam R. Frequency, awareness, treatment and control of hypertension in the over 40 population of Erzincan. Turk Silahli Kuvvetleri Koruyucu Hekim Bul. 2014;13(5):357-66. [Crossref] [PubMed] [PMC]
- Akgol J, Eser E, Olmez E. Factors predicting treatment compliance among hypertensive patients in an urban area. Medicine Science. 2017;6(3):447-56. [Link]
- Yoloğlu AC, Kurt AÖ, Sarıkaya Levent Y, Levent T, Burat S, Karaca S, et al. Sağlık eşitsizlikleri, DSÖ Yaşam Kalitesi Ölçeği üzerinden bir değerlendirme: Mersin İli Mezitli ilçesi örneği [Health inequalities, and evaluation through WHO Quality of Life Scale: the case of Mersin Province Mezitli district]. Journal of Planning. 2020;30(1):66-88. [Link]
- Sözmen K, Ergör G, Ünal B. Hipertansiyon sıklığı, farkındalığı, tedavi alma ve kan basıncı kontrolünü etkileyen etmenler [Determinants of prevalence, awareness, treatment and control of high blood pressure]. Dicle Medical Journal. 2015;42(2):199-207. [Link]
- Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529-32. [Crossref] [PubMed]
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. Erratum in: JAMA. 2014;311(17):1809. [Crossref] [PubMed]
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52. [Crossref] [PubMed]
- Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018. NCHS Data Brief. 2020;(364):1-8. [PubMed]
- Adeloye D, Owolabi EO, Ojji DB, Auta A, Dewan MT, Olanrewaju TO, et al. Prevalence, awareness, treatment, and control of hypertension in Nigeria in 1995 and 2020: a systematic analysis of current evidence. J Clin Hypertens (Greenwich). 2021;23(5):963-77. [Crossref] [PubMed] [PMC]
- Okello S, Muhihi A, Mohamed SF, Ameh S, Ochimana C, Oluwasanu AO, et al. Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sectional study of seven communities in East and West Africa (SevenCEWA). BMC Public Health. 2020;20(1):1706. [Crossref] [PubMed] [PMC]
- Önen C, Güneş G. Relationship between regional food and hypertension in the East of Turkey. International Journal of Community Medicine And Public Health. 2019;6(6):2306-12. [Crossref]
- Onat A. TEKHARF 2017 Tıp Dünyasının Kronik Hastalıklara Yaklaşımına Öncülük. İstanbul: Logos Yayıncılık; 2017. [Link]
- Ulusoy Ş, Özkan G, Arıcı M, Derici Ü, Akpolat T, Şengül Ş, et al; Turkish Society of Hypertension and Renal Diseases. Which out-of-office measurement technique should be used for diagnosing hypertension in prehypertensives? J Hum Hypertens. 2020;34(8):586-92. [Crossref] [PubMed] [PMC]
- Shen L, Wang L, Hu Y, Liu T, Guo J, Shen Y, et al. Associations of the ages at menarche and menopause with blood pressure and hypertension among middle-aged and older Chinese women: a cross-sectional analysis of the baseline data of the China Health and Retirement Longitudinal Study. Hypertens Res. 2019;42(5):730-8. [Crossref] [PubMed]
- Mboera LE, Kishamawe C, Rumisha SF, Chiduo MG, Kimario E. Patterns and trends of hospital mortality due to non-communicable diseases and injuries in Tanzania: a 10-year retrospective analysis. Research Square 2020. 2020:1-19. [Link]
- Awuah RB, Anarfi JK, Agyemang C, Ogedegbe G, Aikins Ad. Prevalence, awareness, treatment and control of hypertension in urban poor communities in Accra, Ghana. J Hypertens. 2014;32(6):1203-10. [Crossref] [PubMed]
- Salazar MR, Garcia Vazquez F, Espeche WG, Marquez D, Becerra P, Martinez Marissi E, et al. May Measurement Month 2019: an analysis of blood pressure screening results from Argentina. Eur Heart J Suppl. 2021;23(Suppl B):B12-B14. [Crossref] [PubMed] [PMC]
- Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: evidence from the Ghana demographic and health survey. PLoS One. 2018;13(11):e0205985. [Crossref] [PubMed] [PMC]
- Yurdakul S, Aytekin S. Kadınlarda hipertansiyon [Hypertension in women]. Turk Kardiyol Dern Ars. 2010;38 Suppl 1:25-31. Turkish. [PubMed]
- Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-9. [Crossref] [PubMed]
- de Souza Filho ZA, Ferreira AA, Dos Santos J, Meira KC, Pierin AMG. Cardiovascular risk factors with an emphasis on hypertension in the Mura Indians from Amazonia. BMC Public Health. 2018;18(1):1251. [Crossref] [PubMed] [PMC]
- Radkevich LA. Overweight and obesity as the risk factors for leukemia in the mediterranean countries. Journal of Obesity and Chronic Diseases, 2020;4(1):23-34. [Crossref]
- Xu X, Ding X, Zhang X, Su S, Treiber FA, Vlietinck R, et al. Genetic and environmental influences on blood pressure variability: a study in twins. J Hypertens. 2013;31(4):690-7. [Crossref] [PubMed] [PMC]
.: Process List